David VanderWeele
9PUBLICATIONS
93CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 25, 2026
Carboplatin, Cabazitaxel, and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase II Study.Emmanuel S Antonarakis, Qing Cao, Victoria Catharine
|Jan 13, 2026
MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer.Surendra Gulla, Tej Sharma, Ephraim Gardner
|Nov 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.Deaglan McHugh, Matthew Dallos, Min Yuen Teo
|Mar 26, 2025
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer.Rahul R Aggarwal, Jacqueline Vuky, David VanderWeele
|Mar 10, 2025
Response to pembrolizumab in advanced prostate cancer with predictive biomarkers.Nicole J Altomare, Yutai Li, Clayton Neill
|Oct 17, 2023
Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits.Ravi A Madan, Fatima Karzai, David J VanderWeele
Pageof 2
Frequent Collaborators
3 joint publications
Fatima Karzai
2 joint publications
Remi Adelaiye-Ogala
2 joint publications
Ravi A Madan
2 joint publications
Alicia K Morgans
2 joint publications
Adam G Sowalsky
1 joint publications
Berkley E Gryder
1 joint publications
Stephanie M Walker
1 joint publications
Scott Wilkinson
1 joint publications
Eric J Small
1 joint publications
Nicolas T Terrigino
